Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Factors Affecting the Seroconversion Rate of 12-Month-Old Babies After the First Injection of Measles Vaccine in the Southeast of Iran Publisher Pubmed



Zahraei SM1 ; Izadi S2 ; Mokhtariazad T3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Centre for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran
  2. 2. Associate Professor of Epidemiology, Health Promotion Research Centre, School of Public Health, Zahedan University of Medical Sciences, Zahedan, Iran
  3. 3. Professor of Virology, National Reference Laboratory for Measles and Rubella, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Human Vaccines and Immunotherapeutics Published:2016


Abstract

Within the past few years, several measles outbreaks have occurred in the southeast of Iran. To learn about the effectiveness of the immunization services for producing a serologic response against measles, this follow-up study was designed and implemented in the southeast of Iran. In Iran, all routine immunization services provided by the public sector are free of charge. The follow-up study was designed and implemented in 5 Urban Health Centers located in 3 districts of Sistan-va-BaluchestanProvince, Iran. In the pre-vaccination phase, 270 12-month-old babies were blood sampled; and in the post-vaccination phase, 4 to 7 weeks after Measles, Mumps, Rubella (MMR) vaccination, 236 of them were blood sampled (34 dropouts), and their sera were tested for IgG anti-measles antibodies, using indirect ELISA, in the National Reference Measles Laboratory. Out of the 236 participants, who had been blood sampled in the post-vaccination phase, 10 (3.7%) were excluded from the calculations of seroconversion rate, because they had protective levels of antibody before the vaccination. The seroconversion rate for the remaining 226 participants was 91.2% (95% confidence interval: 86.7 to 94.5). Among the variables studied, stunting (height-for-age z-score < −2) showed a strong relationship with the remaining seronegative after the vaccination (odds ratio = 5.6; 95% confidence interval: 1.7–18.2). The chance of seroconversion was inversely related to the mothers' levels of education (up to 9 y of education vs. above nine years) (odds ratio = 0.2; 95% confidence interval: 0.06–0.4). In the study population, the seroconversion rates for anti-measles antibodies after MMR vaccination are acceptable, even though in order to achieve the elimination goal, higher standards need to be achieved. © 2016 Ministry of Health, I. R. Iran.
Related Docs
1. Seroconversion Rates Following 2 Doses of Measles- Mumps- Rubella Vaccination Given at the Ages 12 and 18 Months: Data for Possible Additional Dose at Older Age, BMC Immunology (2022)
2. Measles and Rubella Serosusceptibity Among Population Vaccinated With Different Schedules: The Potential Impact on Measles-Rubella Elimination in Iran, BMC Infectious Diseases (2021)
3. A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents, Iranian Journal of Public Health (2022)
4. Comparison of Neutralizing Antibody Titers Against Outbreak-Associated Measles Genotypes (D4, H1 and B3) in Iran, Pathogens and Disease (2021)
5. Seroprevalence of Anti-Rubella and Anti-Measles Antibodies in Women at the Verge of Marriage in Iran, Vaccine (2020)
6. Anti-Rubella, Mumps and Measles Igg Antibodies in Medical Students of Tehran University, Iranian Journal of Allergy# Asthma and Immunology (2016)
7. Seroprevalence of Antibodies to Measles and Rubella Eight Months After a Vaccination Campaign in the Southeast of Iran, Human Vaccines and Immunotherapeutics (2018)
8. Head-To-Head Immunogenicity Comparison of Edmonston-Zagreb Vs. Aik-C Measles Vaccine Strains in Infants Aged 8–12 Months: A Randomized Clinical Trial, Vaccine (2018)
Experts (# of related papers)
View all Related Experts
Hiva Saffar (2)
Samaneh Salarvand (1)